Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High‐Risk Patients With Kawasaki Disease

BACKGROUND: Randomized controlled trials previously provided different conclusions about the superiority of adding corticosteroids to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in patients with Kawasaki disease (KD). To further assess this issue,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Ae, Ryusuke, Abrams, Joseph Y., Maddox, Ryan A., Schonberger, Lawrence B., Nakamura, Yosikazu, Kuwabara, Masanari, Makino, Nobuko, Matsubara, Yuri, Kosami, Koki, Sasahara, Teppei, Belay, Ermias D.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660775/
https://ncbi.nlm.nih.gov/pubmed/32811256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015308
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky